Free Nuchal Translucency Calculator

Understanding Nuchal Translucency and the NT Calculator

The nuchal translucency (NT) calculator is an essential tool in first‑trimester pregnancy NT screening. It compares the measured nuchal fold thickness (the fluid‑filled gap behind the fetal neck) against a reference percentile chart. By doing so, it provides a statistical estimate of the likelihood that the pregnancy may be affected by certain genetic disorders. This NT scan risk calculator is typically used in conjunction with other markers — such as maternal age, blood biochemistry (PAPP‑A and hCG), and the presence of the fetal nasal bone — to form a comprehensive risk profile.

An NT scan is performed via ultrasound between 11 and 13+6 weeks of gestation, when the CRL is between 45 and 84 mm. The sonographer measures the maximum thickness of the translucent area at the back of the fetal neck. Because NT thickness normally increases with fetal size, it must be evaluated relative to the crown‑rump length (CRL). A CRL to NT comparison is therefore the foundation of the nuchal translucency calculator.

How the NT Calculator Works

The Expected NT Formula

The calculator uses a linear regression derived from population data to compute the expected NT for a given CRL:

$$\text{Expected NT (mm)} = 0.437 + 0.01969 \times \text{CRL (mm)}.$$

Example: If a fetus has a CRL of 60 mm, the expected NT is $0.437 + 0.01969 \times 60 \approx 1.62$ mm. The actual measurement is then compared to this expectation to determine its percentile position.

Percentile Classification

Once both the NT and CRL are entered, the tool identifies the NT percentile using a reference table. The table below (based on large‑scale fetal biometry studies) shows the 5th, 25th, 50th, 75th, and 95th percentile values for NT thickness across different CRL values.

CRL (mm) →<br>Percentile ↓	45	50	55	60	65	70	75	80
5th	0.70	0.80	0.90	0.95	1.00	1.05	1.10	1.15
25th	0.90	0.95	1.00	1.05	1.10	1.15	1.20	1.25
50th	1.00	1.10	1.20	1.30	1.40	1.50	1.60	1.65
75th	1.10	1.20	1.30	1.40	1.50	1.60	1.70	1.80
95th	1.80	1.90	2.00	2.05	2.15	2.20	2.30	2.35

Table: Nuchal translucency (mm) by CRL and percentile.

A measurement at or below the 95th percentile is considered normal. The commonly cited threshold of 1.9 mm or less at 12 weeks corresponds to approximately the 95th percentile for a CRL of about 55–60 mm.

Interpreting the Results: What Does an Elevated NT Mean?

If the measured NT lies above the 95th percentile — for example, 2.5 mm at 12 weeks — the result is flagged as abnormal. However, an elevated NT is not a diagnosis. Many fetuses with a high NT are perfectly healthy, and false‑positive findings occur. The risk information should be seen as a screening result that prompts further investigation.

Next Steps After an Abnormal NT

When an abnormal NT is identified, the healthcare provider will often recommend additional tests to confirm or exclude a chromosomal abnormality. These may include:

• NIFTY (non‑invasive prenatal testing) – analyzing cell‑free fetal DNA in the mother’s blood.
• Amniocentesis – sampling of amniotic fluid.
• Chorionic villus sampling (CVS) – biopsy of placental tissue.
• Cordocentesis – percutaneous umbilical blood sampling.

The choice of test depends on the level of risk, gestational age, and the patient’s preferences.

Risk Stratification by NT Thickness

The relationship between NT thickness and adverse outcomes is strong. The following table, based on clinical outcome data, shows how the percentages of healthy births, genetic defects, fetal death, and major abnormalities vary with NT measurement.

NT Measurement	Healthy Babies Born	Genetic Defect	Fetal Death	Major Abnormalities
Below 95th percentile	97%	0.2%	1.3%	1.6%
95th–99th percentile	93%	3.7%	1.3%	2.5%
3.5–4.4 mm	70%	21.1%	2.7%	10%
4.5–5.4 mm	50%	33.3%	3.4%	18.5%
5.5–6.4 mm	30%	50.5%	10.1%	24.2%
6.5 mm or more	15%	64.5%	19%	46.2%

Table: Outcome rates stratified by NT thickness categories.

Key genetic conditions associated with increased NT include:

• Down syndrome (trisomy 21) – one extra copy of chromosome 21. Effects vary widely but often involve intellectual disability and congenital heart defects.
• Edwards syndrome (trisomy 18) – extra chromosome 18; most affected infants do not survive past one year.
• Patau syndrome (trisomy 13) – extra chromosome 13; severe abnormalities and usually fatal within the first year.
• Turner syndrome (monosomy X) – missing one X chromosome in females; typically milder clinical course, but often leads to infertility.

Important Clinical Considerations

• The NT calculator is a screening tool, not a diagnostic test. A normal result cannot guarantee a healthy baby, and an abnormal result does not confirm a disease.
• Combined first‑trimester screening that integrates NT, maternal age, PAPP‑A, and hCG provides a more accurate risk estimate.
• Always consult a physician to interpret the results and discuss appropriate follow‑up. The calculator is designed to assist decision‑making, not to replace professional medical advice.

The nuchal translucency calculator offers a quick, evidence‑based method for assessing one of the earliest ultrasound markers. By understanding how the calculator derives the percentile and risk estimates, users can better appreciate the strengths and limitations of this screening approach in modern obstetrics.